PPARα mediates transcriptional upregulation of novel organic cation transporters-2 and -3 and enzymes involved in hepatic carnitine synthesis

Experimental Biology and Medicine

Volumn 233, Issue 3, 2008, Pages 356-365

  Koch, Alexander ^a   König, Bettina ^a   Stangl, Gabriele I ^a   Eder, Klaus ^a,b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Institut fur Ernahrungswissenschaften   (Germany)

Author keywords

Carnitine; Mice; Novel organic cation transporter (OCTN); Peroxisome proliferator activated receptor (PPAR)

Indexed keywords

CARNITINE; MESSENGER RNA; ORGANIC CATION TRANSPORTER 2; ORGANIC CATION TRANSPORTER 3; OXIDOREDUCTASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HOMEOSTASIS; KIDNEY; LIVER; LIVER METABOLISM; MALE; MOUSE; MUSCLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMA; SMALL INTESTINE; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; BETAINE; BODY WEIGHT; CARNITINE; LIVER; LYSINE; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; ORGAN SIZE; ORGAN SPECIFICITY; ORGANIC CATION TRANSPORT PROTEINS; PPAR ALPHA; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UP-REGULATION;

MUS;

EID: 40149101595     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0706-RM-168     Document Type: Article

References (46)

1. McGarry JD, Brown NF. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244:1-14, 1997.
2. Brass EP. Pivalate-generating prodrugs and carnitine homeostasis in man. Pharmacol Rev 54:589-598, 2002.
3. Steiber A, Kerner J, Hoppel CL. Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Asp Med 25:455-473, 2004.
4. Lohninger A, Pittner G, Pittner F. L-carnitine: new aspects of a known compound - a brief survey. Chem Mon 136:1255-1266, 2005.
5. Rebouche CJ, Seim H. Carnitine metabolism and its regulation in microorganisms and mammals. Annu Rev Nutr 18:39-61, 1998.
6. Vaz FM, Wanders RJ. Carnitine biosynthesis in mammals. Biochem J 361:417-429, 2002.
7. van Vlies N, Wanders RJ, Vaz FM. Measurement of carnitine biosynthesis enzyme activities by tandem mass spectrometry: differences between the mouse and the rat. Anal Biochem 354:132-139, 2006.
8. Lahjouji K, Mitchell GA, Qureshi IA. Carnitine transport by organic cation transporters and systemic carnitine deficiency. Mol Genet Metab 73:287-297, 2001.
9. Tein I. Carnitine transport: pathophysiology and metabolism of known defects. J Inherit Metab Dis 26:147-169, 2003.
10. Tamai I, Yabuuchi H, Nezu J, Sai Y, Oku A, Shimane M, Tsuji A. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419:107-111, 1997.
11. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, Tsuji A. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 273:20378-20382, 1998.
12. Tamai I, Ohashi R, Nezu JI, Sai Y, Kobayashi D, Oku A, Shimane M, Tsuji A. Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 275:40064-40072, 2000.
13. +-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther 291:778-784, 1999.
14. Ohashi R, Tamai I, Nezu Ji J, Nikaido H, Hashimoto N, Oku A, Sai Y, Shimane M, Tsuji A. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. Mol Pharmacol 59:358-366, 2001.
15. Wu X, Huang W, Prasad PD, Seth P, Rajan DP, Leibach FH, Chen J, Conway SJ, Ganapathy V. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 290:1482-1492, 1999.
16. Slitt AL, Cherrington NJ, Hartley DP, Leazer MT, Klaassen CD. Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels. Drug Metab Dispos 30:212-219, 2002.
17. +-independent L-carnitine transporter in enterocytes basolateral membrane. J Cell Physiol 202:929-935, 2005.
18. Luci S, Geissler S, König B, Koch A, Stangl GI, Hirche F, Eder K. PPARα agonists up-regulate organic cation transporters in rat liver cells. Biochem Biophys Res Commun 24:704-708, 2006.
19. Koch A, König B, Luci S, Stangl GI, Eder K. Dietary oxidized fat upregulates expression of organic cation transporters in liver and small intestine and increases the carnitine concentration in the liver of rats. Br J Nutr 98:882-889, 2007.
20. Chao P-M, Chao C-Y, Lin F-J, Huang C-J. Oxidized frying oil upregulates hepatic acyl-CoA oxidase and cytochrome P450 4A1 genes in rats and activates PPARα. J Nutr 131:3166-3174, 2001.
21. Chao P-M, Hsu SC, Lin F-J, Li YJ, Huang C-J. The up-regulation of hepatic acyl-CoA oxidase and cytochrome P450 4A1 mRNA expression by dietary oxidized frying oil is comparable between male and female rats. Lipids 39:233-238, 2004.
22. Sülzle A, Hirche F, Eder K. Thermally oxidized dietary fat upregulates the expression of target genes of PPAR alpha in rat liver. J Nutr 134:1375-1383, 2004.
23. Luci S, König B, Giemsa B, Huber S, Hause G, Kluge H, Stangl GI, Eder K. Feeding of a deep-fried fat causes PPARα activation in the liver of pigs as a non-proliferating species. Br J Nutr 97:872-882, 2007.
24. Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37:907-925, 1996.
25. Paul HS, Adibi SA. Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation. J Clin Invest 64:405-412, 1979.
26. Senekeo-Effenberger K, Chen S, Brace-Sinnokrak E, Bonzo JA, Yueh MF, Argikar U, Kaeding J, Trottier J, Remmel RP, Ritter JK, Barbier O, Tukey RH. Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3- xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor alpha activation. Drug Metab Dispos 35:419-427, 2007.
27. National Research Council. Nutrient Requirements of Laboratory Animals (4th revised ed.). Washington DC: National Academy Press, 1995.
28. König B, Eder K. Differential action of 13-HPODE on PPARα downstream genes in rat Fao and human HepG2 hepatoma cell lines. J Nutr Biochem 17:410-418, 2006.
29. König B, Koch A, Spielmann J, Hilgenfeld C, Stangl GI, Eder K. Activation of PPARα lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2. Biochem Pharmacol 73:574-585, 2007.
30. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45, 2001.
31. Vernez L, Wenk M, Krähenbühl S. Determination of carnitine and acylcarnitines in plasma by high-performance liquid chromatography/electrospray ionization ion trap tandem mass spectrometry. Rapid Commun Mass Spectrom 18:1233-1238, 2004.
32. Tugwood JD, Issemann I, Anderson RG, Bundell KR, McPheat WL, Green S. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J 11:433-439, 1992.
33. Escher P, Braissant O, Basu-Modak S, Michalik L, Wahli W, Desvergne B. Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 142:4195-4202, 2001.
34. Qi C, Zhu Y, Reddy JK. Peroxisome proliferator-activated receptors, coactivators, and downstream targets. Cell Biochem Biophys 32:187-204, 2002.
35. Paul HS, Gleditsch CE, Adibi SA. Mechanism of increased hepatic concentration of carnitine by clofibrate. Am J Physiol 251:E311-E315, 1986.
36. Rebouche CJ. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci 1033:30-41, 2004.
37. Frohlich J, Seccombe DW, Hahn P, Dodek P, Hynie I. Effect of fasting on free and esterified carnitine levels in human serum and urine: correlation with serum levels of free fatty acids and beta-hydroxybutyrate. Metabolism 27:555-561, 1978.
38. Hokland BM, Bremer J. Metabolism and excretion of carnitine and acylcarnitines in the perfused rat kidney. Biochim Biophys Acta 886: 223-230, 1986.
39. Zamora S, Benador N, Lacourt G, Girardin E. Renal handling of carnitine in ill preterm and term neonates. J Pediatr 127:975-978, 1995.
40. Taylor PM. Absorbing competition for carnitine. J Physiol 532:283, 2001.
41. van Vlies N, Ferdinandusse S, Turkenburg M, Wanders RJ, Vaz FM. PPARalpha-activation results in enhanced carnitine biosynthesis and OCTN2-mediated hepatic carnitine accumulation. Biochim Biophys Acta 1767:1134-1142, 2007.
42. Kato Y, Sugiura M, Sugiura T, Wakayama T, Kubo Y, Kobayashi D, Sai Y, Tamai I, Iseki S, Tsuji A. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse. Mol Pharmacol 70:829-837, 2006.
43. Koepsell H, Endou H. The SLC22 drug transporter family. Pflugers Arch 447:666-676, 2004.
44. Lahjouji K, Elimrani I, Lafond J, Leduc L, Qureshi IA, Mitchell GA. LCarnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2. Am J Physiol Cell Physiol 287:C263-269, 2004.
45. Grube M, Meyer zu Schwabedissen HE, Präger D, Haney J, Möritz KU, Meissner K, Rosskopf D, Eckel L, Böhm M, Jedlitschky G, Kroemer HK. Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5). Circulation 113:1114-1122, 2006.
46. Hirano T, Yasuda S, Osaka Y, Kobayashi M, Itagaki S, Iseki K. Mechanism of the inhibitory effect of zwitterionic drugs (levofloxacin and grepafloxacin) on carnitine transporter (OCTN2) in Caco-2 cells. Biochim Biophys Acta 1758:1743-1750, 2006.